Syntara Limited
🏢 View company profile →3Patents
3Active
3Granted
57Portfolio score
Filing activity: Aug 2, 2019 → Apr 5, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12428370B2 | Haloallylamine dual amine oxidase inhibitors | Human Necessities | 0 | Active |
| US12178791B2 | Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12233056B2 | Lysyl oxidase inhibitors for treating myeloid malignancies | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.